HADV (Health Advance) ROCE %: -10.79% (As of Sep. 2017)


What is Health Advance ROCE %?

Health Advance HADV ROCE % is -10.79% as of Sep. 2017.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Health Advance's annualized ROCE % for the quarter that ended in Sep. 2017 was -10.79%.

Health Advance  (OTCPK:HADV) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Health Advance ROCE % Related Terms

Health Advance ROCE % Historical Data

* Premium members only.

The historical data trend for Health Advance's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health Advance ROCE % Chart

Health Advance Annual Data
Trend Jul11 Jul12 Jul13 Jul14 Jul15
ROCE %
-309.09 0.00 0.00 0.00 0.00

Health Advance Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Sep17
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -2.74 -10.79

Health Advance ROCE % Calculation

Health Advance's annualized ROCE % for the fiscal year that ended in Jul. 2015 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jul. 2015 )  (A: Jul. 2014 )(A: Jul. 2015 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jul. 2015 )  (A: Jul. 2014 )(A: Jul. 2015 )
=-0.067/( ( (0 - 0.105) + (0 - 0.13) )/ 2 )
=-0.067/( (-0.105+-0.13)/ 2 )
=-0.067/-0.1175
=57.02 %

Health Advance's ROCE % of for the quarter that ended in Sep. 2017 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2017 )  (Q: Apr. 2017 )(Q: Sep. 2017 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2017 )  (Q: Apr. 2017 )(Q: Sep. 2017 )
=-0.296/( ( (2.99 - 0.185) + (2.965 - 0.283) )/ 2 )
=-0.296/( ( 2.805 + 2.682 )/ 2 )
=-0.296/2.7435
=-10.79 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2017) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -10.79% mean?
Health Advance (HADV) has a ROCE % of -10.79% as of Sep. 2017.
Is Health Advance's ROCE % too high?
Health Advance's current ROCE % is -10.79%.
How does Health Advance's ROCE % compare to MYDP and HEWA?
Health Advance's ROCE % of -10.79% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.43. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.43, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health Advance's current ROCE % is -10.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Advance stock overvalued right now?
Health Advance (HADV) has a current ROCE % of -10.79%. The current ROCE % is -10.79%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Health Advance (HADV), the current ROCE % is -10.79% as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Health Advance Business Description

Address 9131 Keele Street, Suite A4, Vaughan, ON, CAN, L4K 0G7
Health Advance Inc is engaged in the retail domain. The Company is focused on products that are oriented to health and wellness. The first example of this is a proprietary CBD-infused wine beverage. The company is in the analysis stage for Immune boosting nutraceuticals, and human wellness products.